ISIN | CH0116771202 |
---|---|
Valor Number | 1167712 |
Bloomberg Global ID | BBG0017CJH50 |
Fund Name | LO Funds (CH) - Swiss Equity Factor Enhanced P D |
Fund Provider |
Lombard Odier Asset Management (Switzerland) SA
Genève, Switzerland Phone: +41 22 709 21 11 E-Mail: contact@lombardodier.com Web: www.lombardodier.com |
Fund Provider | Lombard Odier Asset Management (Switzerland) SA |
Representative in Switzerland | |
Distributor(s) |
Lombard Odier Funds (Switzerland) S.A Petit-Lancy Phone: +41 22 709 21 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the Fund is to track the SMI as exactly as possible while minimizing transaction costs. This is achieved by investing directly in every single underlying security contained in the reference index and in the same proportion (Full index replication methodology). |
Peculiarities |
Current Price * | 206.77 CHF | 31.03.2025 |
---|---|---|
Previous Price * | 210.32 CHF | 28.03.2025 |
52 Week High * | 213.06 CHF | 03.03.2025 |
52 Week Low * | 186.74 CHF | 20.12.2024 |
NAV * | 206.77 CHF | 31.03.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 81,176,152 | |
Unit/Share Assets *** | 936,294 | |
Trading Information SIX |
YTD Performance | +8.73% |
31.12.2024 - 31.03.2025
31.12.2024 31.03.2025 |
---|---|---|
1 month | -1.86% |
28.02.2025 - 31.03.2025
28.02.2025 31.03.2025 |
3 months | +8.73% |
31.12.2024 - 31.03.2025
31.12.2024 31.03.2025 |
6 months | +1.28% |
30.09.2024 - 31.03.2025
30.09.2024 31.03.2025 |
1 year | +7.90% |
02.04.2024 - 31.03.2025
02.04.2024 31.03.2025 |
2 years | +9.32% |
31.03.2023 - 31.03.2025
31.03.2023 31.03.2025 |
3 years | -0.21% |
31.03.2022 - 31.03.2025
31.03.2022 31.03.2025 |
5 years | +41.13% |
31.03.2020 - 31.03.2025
31.03.2020 31.03.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 13.16% | |
---|---|---|
Roche Holding AG | 12.60% | |
Novartis AG Registered Shares | 11.96% | |
Compagnie Financiere Richemont SA Class A | 6.14% | |
Zurich Insurance Group AG | 5.37% | |
UBS Group AG | 5.28% | |
ABB Ltd | 4.25% | |
Holcim Ltd | 2.88% | |
Swiss Re AG | 2.75% | |
Sika AG | 2.44% | |
Last data update | 28.02.2025 |
TER | 1.21% |
---|---|
TER date | 31.01.2020 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.40% |
Ongoing Charges *** | 0.40% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |